24 Jan 2020
Article focused on describing the epidemiological, clinical, laboratory, and radiological characteristics of patients confirmed to have 2019-nCoV infection. The treatment, and treatment results is then compared to the clinical features between intensive care unit (ICU) and non-ICU patients.
Also By
ISARIC
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando
Please Sign in (or Register) to view further.